IOL Chemicals And Pharmaceuticals (NSE:IOLCP) PE Ratio without NRI: 26.87 (As of Jun. 26, 2026) — 68% Above Median


NSE:IOLCP IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
63 GF Score
Price ₹133.66
GF Value ₹93.66
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is IOL Chemicals And Pharmaceuticals PE Ratio without NRI?

IOL Chemicals And Pharmaceuticals NSE:IOLCP +2.06% 63 PE Ratio without NRI is 26.87 as of Jun. 26, 2026, which is 68% above its 10-year median of 16.00. GuruFocus rates NSE:IOLCP with a GF Score™ of 63/100 and a GF Value™ of ₹93.66 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 653 Drug Manufacturers companies, IOL Chemicals And Pharmaceuticals ranks worse than 61.87% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-26), IOL Chemicals And Pharmaceuticals's share price is ₹133.66. IOL Chemicals And Pharmaceuticals's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.98. Therefore, IOL Chemicals And Pharmaceuticals's PE Ratio without NRI for today is 26.87.

During the past 13 years, IOL Chemicals And Pharmaceuticals's highest PE Ratio without NRI was 113.33. The lowest was 2.59. And the median was 16.00.

IOL Chemicals And Pharmaceuticals's EPS without NRI for the three months ended in Mar. 2026 was ₹1.81. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.98.

As of today (2026-06-26), IOL Chemicals And Pharmaceuticals's share price is ₹133.66. IOL Chemicals And Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.69. Therefore, IOL Chemicals And Pharmaceuticals's PE Ratio (TTM) for today is 28.50.

During the past years, IOL Chemicals And Pharmaceuticals's highest PE Ratio (TTM) was 115.29. The lowest was 2.59. And the median was 16.08.

IOL Chemicals And Pharmaceuticals's EPS (Diluted) for the three months ended in Mar. 2026 was ₹1.81. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.69.

IOL Chemicals And Pharmaceuticals's EPS (Basic) for the three months ended in Mar. 2026 was ₹1.81. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.69.


IOL Chemicals And Pharmaceuticals  (NSE:IOLCP) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


IOL Chemicals And Pharmaceuticals PE Ratio without NRI Related Terms


IOL Chemicals And Pharmaceuticals PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for IOL Chemicals And Pharmaceuticals's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IOL Chemicals And Pharmaceuticals PE Ratio without NRI Chart

IOL Chemicals And Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.62 11.91 15.81 17.79 14.62

IOL Chemicals And Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.79 27.21 25.94 19.42 14.62

NSE:IOLCP vs ZTS: PE Ratio without NRI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IOL Chemicals And Pharmaceuticals PE Ratio without NRI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where IOL Chemicals And Pharmaceuticals's PE Ratio without NRI falls into.


NSE:IOLCP
63GF Score
IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IOL Chemicals And Pharmaceuticals PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

IOL Chemicals And Pharmaceuticals's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=133.66/4.975
=26.87

IOL Chemicals And Pharmaceuticals's Share Price of today is ₹133.66.
IOL Chemicals And Pharmaceuticals's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4.98.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 26.87 mean?
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a PE Ratio without NRI of 26.87 as of Jun. 26, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. This is 68% above median its historical median of 16.00. Over the past decade, IOL Chemicals And Pharmaceuticals' PE Ratio without NRI has ranged from 2.59 to 113.33. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #404 out of 653 companies in the Drug Manufacturers industry, placing it in the top 61.9%.
Is IOL Chemicals And Pharmaceuticals' PE Ratio without NRI too high?
IOL Chemicals And Pharmaceuticals' current PE Ratio without NRI of 26.87 is 68% above median its 10-year median of 16.00. Over the past 10 years, this metric has ranged from a low of 2.59 to a high of 113.33. The Drug Manufacturers industry median PE Ratio without NRI is 20.26. IOL Chemicals And Pharmaceuticals' value of 26.87 is 32.6% above this industry median. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #404 out of 653 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' PE Ratio without NRI compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #404 out of 653 companies for PE Ratio without NRI. This places IOL Chemicals And Pharmaceuticals in the lower half of its industry. The industry median PE Ratio without NRI is 20.26. IOL Chemicals And Pharmaceuticals' value of 26.87 is 32.6% above this benchmark. Historically, IOL Chemicals And Pharmaceuticals' own PE Ratio without NRI has ranged from 2.59 to 113.33 over the past decade. While the company's 10-year median is 16.00 vs. the industry median of 20.26, IOL Chemicals And Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Drug Manufacturers company?
The median PE Ratio without NRI among Drug Manufacturers companies is 20.26, based on 653 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IOL Chemicals And Pharmaceuticals's current PE Ratio without NRI of 26.87 is 32.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median PE Ratio without NRI is 20.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOL Chemicals And Pharmaceuticals's current PE Ratio without NRI is 26.87, which is 68% above median its own 10-year median of 16.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹93.66, compared to a current price of ₹133.66 — trading 42.7% above its estimated fair value. The current PE Ratio without NRI is 26.87, which is 68% above median its 10-year median of 16.00 and 32.6% above the Drug Manufacturers industry median of 20.26. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current PE Ratio without NRI is 26.87 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?

Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued. The current stock price of ₹133.66 is trading 42.7% above its estimated GF Value™ of ₹93.66. GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:IOLCP:

  • PE Ratio without NRI: 26.87 (68% above median its 10-year median of 16.00)
  • GF Value™: ₹93.66 vs. price of ₹133.66 (42.7% above fair value)
  • GF Score™: 63/100 with 5 warning signs
  • Industry Position: 32.6% above the Drug Manufacturers median (#404 of 653)

No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IOL Chemicals And Pharmaceuticals Business Description

Other Exchanges 524164:India
Address 85, Industrial Area, A, Ludhiana, PB, IND, 141 003
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
63GF Score

Get the complete analysis for NSE:IOLCP

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹133.66
Price
₹93.66
GF Value